Patients with neuromyelitis optica spectrum disorder treated tocilizumab may experience decreased risks of relapse or disability progression compared to before treatment, but it is uncertain whether these changes can be entirely attributed (TCZ) treatment.
 TCZ might better than azathioprine for patients in reducing risk.
 improve have no impact on pain and fatigue measures dis...